author-photo

Giles F. Whalen

University of Massachusetts Medical School
University of Massachusetts Amherst

111

Papers

2978

Citations

Citation Trend

Filter By

Papers (73) Sort By

Journal Conference Others

501 Survival and immune response data from intratumoral INT230–6 alone (IT-01) and with pembrolizumab [KEYNOTE-A10] in subjects with locally advanced, unresectable and metastatic solid tumors

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Early results of intratumoral INT230-6 alone or in combination with ipilimumab in subjects with advanced sarcomas.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Coordination and optimization of PET/CT and COVID-19 vaccination;Lessons learned in the early stages of mass vaccination

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (3)
536 Intratumoral INT230–6 shows a favorable safety profile and early signs of efficacy in advanced soft tissue sarcoma with monotherapy and in combination with ipilimumab [Intensity IT-01; BMS#CA184–592]

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacodynamic, safety, and efficacy results of a phase I/II trial of intratumoral INT230-6 alone (IT-01) or in combination with pembrolizumab (PEM) (Keynote A10) in patients with advanced solid tumors.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Short-term Preoperative Diet Decreases Bleeding After Partial Hepatectomy: Results From a Multi-institutional Randomized Controlled Trial

2019 Annals of Surgery
Show All
- Source
- Cite
- Save
Citations (9)
Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool

2019 Oncotarget
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 1070: Evaluation of human NK cell responses to PDX tumors in humanized NOD-scid IL2rgnull(NSG) mice expressing human IL15

2019 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (0)
Safety profile of INT230-6, a novel intratumoral (IT) formulation, during injections into a variety of refractory deep and superficial tumors with evidence of tumor regression and immune activation.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)